Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Bull Exp Biol Med ; 2024 Sep 11.
Artículo en Inglés | MEDLINE | ID: mdl-39259466

RESUMEN

The dynamics of nephropathy development in rats with type 2 diabetes mellitus, caused by a high-fat diet and the streptozotocin administration (25 mg/kg), and metabolic syndrome, caused by addition of 20% fructose solution to the diet, was evaluated during the experiment. Models with moderate severity of metabolic changes without significant changes in body weight were obtained after 24 weeks. To study neuropathy severity, the method of electroneuromyography was used; the velocities of motor and sensory excitation propagation along the caudal nerve fibers were measured. In modeled diabetes mellitus against the background of hyperglycemia, a marked decrease in motor and sensory propagation rates was observed, and an increase in the response durations was noted from week 12 to week 24, indicating pronounced neuropathy. In the fructose model, the motor response duration increased from week 12, which possibly indicates the development of peripheral neuropathy.

2.
Acta Naturae ; 16(2): 40-49, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39188264

RESUMEN

The effects of the antioxidant dihydroquercetin (DHQ) were studied in a model of pulmonary fibrosis. DHQ penetration into the lesion was facilitated by encapsulation into liposomes. Pulmonary fibrosis was modeled in rats by intratracheal injection of bleomycin. For the first 7 days, the rats in the treatment group received a liposomal emulsion with DHQ, while in the comparator group rats received saline. In the control group, intact rats did not receive any exposure. Thirty days after the initiation, lung function and the pathological lesion volume were assessed by 7T 1H MRI and the lungs were taken for histologic examination. The proportion of fibrous tissue was counted by Masson's trichrome staining. Both experimental groups were characterized by a significant functional pulmonary deficiency, with low mortality and a small lesion area. In the rats treated with DHQ, the distribution of fibrous tissue was significantly altered. Significantly more fibrous tissue was found in the center of the lesion, while significantly less was in the interstitial space of alveoli. Lung density at the same time was lower in the treated lungs. Dihydroquercetin encapsulated in liposomes affects the mechanisms of bleomycin-induced pulmonary fibrosis progression in rats. While accelerated fibrosis of the lesion can restrict inflammatory processes, delayed fibrosis of the interstitium can further improve the functional state of the lungs.

3.
Bull Exp Biol Med ; 177(3): 395-400, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39134815

RESUMEN

We compared 2 models of metabolic syndrome in rats: high-fat diet (58% calories) with single streptozotocin injection at a dose of 25 mg/kg and replacement of water with 20% fructose solution. The model with fructose solution did not cause the main signs of metabolic syndrome over 24 weeks: concentrations of glucose, triglycerides, cholesterol, weight, and BP did not significantly differ from the control group (standard diet). At the same time, single streptozotocin administration was followed by the development of persistent hyperglycemia, hypertriglyceridemia, hypercholesterolemia, and signs of visceral obesity. High-fat diet combined with injection of streptozotocin in a low dose can be considered a more representative model of metabolic syndrome in humans.


Asunto(s)
Glucemia , Dieta Alta en Grasa , Síndrome Metabólico , Estreptozocina , Triglicéridos , Animales , Dieta Alta en Grasa/efectos adversos , Ratas , Masculino , Síndrome Metabólico/metabolismo , Triglicéridos/sangre , Triglicéridos/metabolismo , Glucemia/metabolismo , Ratas Wistar , Hiperglucemia/metabolismo , Hiperglucemia/inducido químicamente , Colesterol/sangre , Colesterol/metabolismo , Peso Corporal/efectos de los fármacos , Fructosa/administración & dosificación , Hipertrigliceridemia/metabolismo , Hipertrigliceridemia/inducido químicamente , Hipertrigliceridemia/sangre , Hipertrigliceridemia/etiología , Hipercolesterolemia/metabolismo , Hipercolesterolemia/etiología , Carbohidratos de la Dieta/administración & dosificación , Presión Sanguínea/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA